ACESION PHARMA ApS Financials, key figures and credit report
Gross profit -18 918.4 kDKK FY 2018 -8.4% vs 2017
EBIT -30 541.7 kDKK FY 2018 -3.8% vs 2017
Net debt 7 635.8 kDKK FY 2018 -28.7% vs 2017
Quick ratio 5.5 FY 2018 +2 vs 2017
Income statement (kDKK)
2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -4 722.34 | -8 496.43 | -14 393.71 | -17 450.51 | -18 918.38 |
| Employee benefit expenses | -3 489.19 | -3 857.11 | -8 213.85 | -11 748.18 | -11 519.56 |
| Total depreciation | - 184.46 | - 211.04 | - 213.46 | - 215.15 | - 103.73 |
| EBIT | -8 395.98 | -12 564.58 | -22 821.01 | -29 413.84 | -30 541.68 |
| Other financial income | 4.72 | 3.54 | 76.52 | 28.77 | |
| Other financial expenses | -1.02 | -33.61 | -74.11 | -87.42 | -46.72 |
| Pre-tax profit | -8 392.28 | -12 594.65 | -22 818.60 | -29 472.49 | -30 588.39 |
| Income taxes | 1 937.16 | 2 790.38 | 4 556.34 | 5 500.00 | 5 500.00 |
| Net earnings | -6 455.12 | -9 804.27 | -18 262.26 | -23 972.49 | -25 088.39 |
Assets (kDKK)
2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 629.80 | 563.76 | 350.30 | 135.15 | 31.42 |
| Tangible assets total | 629.80 | 563.76 | 350.30 | 135.15 | 31.42 |
| Investments total | 11.38 | 11.72 | 63.22 | 65.12 | 82.35 |
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 372.06 | 8.90 | 29.93 | 235.48 | 65.74 |
| Current other receivables | 577.41 | 522.60 | 1 117.71 | 1 081.03 | 671.15 |
| Current deferred tax assets | 1 910.21 | 2 790.38 | 4 556.34 | 5 500.00 | 5 500.00 |
| Short term receivables total | 2 859.68 | 3 321.88 | 5 703.99 | 6 816.51 | 6 236.89 |
| Cash and bank deposits | 15 386.08 | 13 390.62 | 33 668.39 | 15 800.09 | 23 028.29 |
| Cash and cash equivalents | 15 386.08 | 13 390.62 | 33 668.39 | 15 800.09 | 23 028.29 |
| Balance sheet total (assets) | 18 886.93 | 17 287.97 | 39 785.91 | 22 816.87 | 29 378.95 |
Equity and liabilities (kDKK)
2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Share capital | 1 313.02 | 1 849.33 | 3 594.50 | 3 594.50 | 5 155.50 |
| Retained earnings | 8 973.60 | 9 490.44 | 28 722.09 | 10 459.83 | 13 436.94 |
| Profit of the financial year | -6 455.12 | -9 804.27 | -18 262.26 | -23 972.49 | -25 088.39 |
| Shareholders equity total | 3 831.50 | 1 535.50 | 14 054.33 | -9 918.16 | -6 495.95 |
| Non-current loans from credit institutions | 13 638.84 | 10 965.52 | 19 862.89 | 26 393.77 | 30 593.39 |
| Non-current liabilities total | 13 638.84 | 10 965.52 | 19 862.89 | 26 393.77 | 30 593.39 |
| Current loans from credit institutions | 2.00 | 4.73 | 53.66 | 122.03 | 70.72 |
| Current trade creditors | 488.08 | 1 414.90 | 2 545.71 | 3 648.52 | 2 124.12 |
| Other non-interest bearing current liabilities | 926.51 | 1 064.24 | 2 000.62 | 2 537.06 | 3 086.67 |
| Accruals and deferred income | 2 303.09 | 1 268.70 | 33.64 | ||
| Current liabilities total | 1 416.59 | 4 786.95 | 5 868.69 | 6 341.26 | 5 281.51 |
| Balance sheet total (liabilities) | 18 886.93 | 17 287.97 | 39 785.91 | 22 816.87 | 29 378.95 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated